Cargando…

Natural products target glycolysis in liver disease

Mitochondrial dysfunction plays an important role in the occurrence and development of different liver diseases. Oxidative phosphorylation (OXPHOS) dysfunction and production of reactive oxygen species are closely related to mitochondrial dysfunction, forcing glycolysis to become the main source of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shenghao, Hao, Liyuan, Hu, Xiaoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469892/
https://www.ncbi.nlm.nih.gov/pubmed/37663261
http://dx.doi.org/10.3389/fphar.2023.1242955
_version_ 1785099548557836288
author Li, Shenghao
Hao, Liyuan
Hu, Xiaoyu
author_facet Li, Shenghao
Hao, Liyuan
Hu, Xiaoyu
author_sort Li, Shenghao
collection PubMed
description Mitochondrial dysfunction plays an important role in the occurrence and development of different liver diseases. Oxidative phosphorylation (OXPHOS) dysfunction and production of reactive oxygen species are closely related to mitochondrial dysfunction, forcing glycolysis to become the main source of energy metabolism of liver cells. Moreover, glycolysis is also enhanced to varying degrees in different liver diseases, especially in liver cancer. Therefore, targeting the glycolytic signaling pathway provides a new strategy for the treatment of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis associated with liver cancer. Natural products regulate many steps of glycolysis, and targeting glycolysis with natural products is a promising cancer treatment. In this review, we have mainly illustrated the relationship between glycolysis and liver disease, natural products can work by targeting key enzymes in glycolysis and their associated proteins, so understanding how natural products regulate glycolysis can help clarify the therapeutic mechanisms these drugs use to inhibit liver disease.
format Online
Article
Text
id pubmed-10469892
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104698922023-09-01 Natural products target glycolysis in liver disease Li, Shenghao Hao, Liyuan Hu, Xiaoyu Front Pharmacol Pharmacology Mitochondrial dysfunction plays an important role in the occurrence and development of different liver diseases. Oxidative phosphorylation (OXPHOS) dysfunction and production of reactive oxygen species are closely related to mitochondrial dysfunction, forcing glycolysis to become the main source of energy metabolism of liver cells. Moreover, glycolysis is also enhanced to varying degrees in different liver diseases, especially in liver cancer. Therefore, targeting the glycolytic signaling pathway provides a new strategy for the treatment of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis associated with liver cancer. Natural products regulate many steps of glycolysis, and targeting glycolysis with natural products is a promising cancer treatment. In this review, we have mainly illustrated the relationship between glycolysis and liver disease, natural products can work by targeting key enzymes in glycolysis and their associated proteins, so understanding how natural products regulate glycolysis can help clarify the therapeutic mechanisms these drugs use to inhibit liver disease. Frontiers Media S.A. 2023-08-17 /pmc/articles/PMC10469892/ /pubmed/37663261 http://dx.doi.org/10.3389/fphar.2023.1242955 Text en Copyright © 2023 Li, Hao and Hu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Li, Shenghao
Hao, Liyuan
Hu, Xiaoyu
Natural products target glycolysis in liver disease
title Natural products target glycolysis in liver disease
title_full Natural products target glycolysis in liver disease
title_fullStr Natural products target glycolysis in liver disease
title_full_unstemmed Natural products target glycolysis in liver disease
title_short Natural products target glycolysis in liver disease
title_sort natural products target glycolysis in liver disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469892/
https://www.ncbi.nlm.nih.gov/pubmed/37663261
http://dx.doi.org/10.3389/fphar.2023.1242955
work_keys_str_mv AT lishenghao naturalproductstargetglycolysisinliverdisease
AT haoliyuan naturalproductstargetglycolysisinliverdisease
AT huxiaoyu naturalproductstargetglycolysisinliverdisease